Pilot study of a preliminary criterion standard for prescription opioid misuse

American Journal on Addictions

Volumn 19, Issue 6, 2010, Pages 523-528

  Smith, Robert C ^a   Frank, Cathy ^b   Gardiner, Joseph C ^a   Lamerato, Lois ^c   Rost, Kathryn M ^d  

^a MICHIGAN STATE UNIVERSITY   (United States)

^b NORTHWESTERN UNIVERSITY   (United States)

^c HENRY FORD HEALTH SYSTEM   (United States)

^d FLORIDA STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CLINICAL ARTICLE; DATA BASE; ELECTRONIC MEDICAL RECORD; EXPERT SYSTEM; GOLD STANDARD; HUMAN; OPIATE ADDICTION; PILOT STUDY; PRESCRIPTION; SCORING SYSTEM;

EID: 78349258969     PISSN: 10550496     EISSN: 15210391     Source Type: Journal    
DOI: 10.1111/j.1521-0391.2010.00084.x     Document Type: Article

References (40)

1. Elliott AM, Smith BH, Penny KI, et al,. The epidemiology of chronic pain in the community. Lancet. 1999; 354: 1248-1252.
2. Verhaak PF, Kerssens JJ, Dekker J, et al,. Prevalence of chronic benign pain disorder among adults: A review of the literature. Pain. 1998; 77: 231-239.
3. Gureje O, Von Korff M, Simon GE, et al,. Persistent pain and well-being: A World Health Organization study in primary care. JAMA. 1998; 77: 147-151.
4. Clark JD,. Chronic pain prevalence and analgesic prescribing in a general medical population. J Pain Symptom Manage. 2002; 23: 131-137.
5. Morasco BJ, Dobscha SK,. Prescription medication misuse and substance use disorder in VA primary care patients with chronic pain. Gen Hosp Psychiatry. 2008; 30: 93-99.
6. Adams NJ, Plane MB, Fleming MF, et al,. Opioids and the treatment of chronic pain in a primary care sample. J Pain Symptom Manage. 2001; 22: 791-796.
7. Michna E, Jamison RN, Pham LD, et al,. Urine toxicology screening among chronic pain patients on opioid therapy: Frequency and predictability of abnormal findings. Clin J Pain. 2007; 23: 173-179.
8. Katz NP, Adams EH, Benneyan JC, et al,. Foundations of opioid risk management. Clin J Pain. 2007; 23: 103-118.
9. Ling W, Wesson D, Smith D,. Abuse of prescription opioids. In:, Graham A, Schultz T, Mayo-Smith M, et al., eds. Principles of Addiction Medicine, 3rd edn. Chevy Chase, MS: American Society of Addiction Medicine, Inc; 2003: 1483-1492.
10. Zerzan JT, Morden NE, Soumerai S, et al,. Trends and geographic variation of opiate medication use in state Medicaid fee-for-service programs, 1996 to 2002. Med Care. 2006; 44: 1005-1010.
11. Birnbaum HG, White AG, Reynolds JL, et al,. Estimated costs of prescription opioid analgesic abuse in the United States in 2001: A societal perspective. Clin J Pain. 2006; 22: 667-676.
12. Olsen Y, Daumit GL, Ford DE,. Opioid prescriptions by U.S. primary care physicians from 1992 to 2001. J Pain. 2006; 7: 225-235.
13. Denisco RA, Chandler RK, Compton WM,. Addressing the intersecting problems of opioid misuse and chronic pain treatment. Exp Clin Psychopharmacol. 2008; 16: 417-428.
14. American Academy of Pain Medicine and the American Pain Society. The use of opioids for the treatment of chronic pain: A consensus statement from the American Academy of Pain Medicine and American Pain Society. Clin J Pain. 1997; 13: 6-8.
15. Chabal C, Miklavz E, Jacobson L, et al,. Prescription opiate abuse in chronic pain patients: Clinical criteria, incidence, and predictors. Clin J Pain. 1997; 13: 150-155.
16. Compton P, Darakjian J, Miotto K,. Screening for addiction in patients with chronic pain and "problematic" substance use: Evaluation of a pilot assessment tool. J Pain Symptom Manage. 1998; 16: 355-363.
17. Jamison RN, Gintner L, Rogers JF, et al,. Disease management for chronic pain: Barriers of program implementation with primary care physicians. Pain Med. 2002; 3: 92-101.
18. Parente ST, Kim SS, Finch MD, et al,. Identifying controlled substance patterns of utilization requiring evaluation using administrative claims data. Am J Manag Care. 2004; 10: 783-790.
19. Ballantyne JC, Mao J,. Opioid therapy for chronic pain. N Engl J Med. 2003; 349: 1943-1953.
20. Smith RC, Lyles JS, Gardiner JC, et al,. Primary care clinicians treat patients with medically unexplained symptoms-A randomized controlled trial. J Gen Intern Med. 2006; 21: 671-677. PMCID: PMC1924714.
21. Chou R, Fanciullo GJ, Fine PG, et al,. Clinical guidelines for the use of chronic opioid therapy in chronic noncancer pain. J Pain. 2009; 10: 113-130.
22. Katz N,. Opioids: After thousands of years, still getting to know you. Clin J Pain. 2007; 23: 303-306.
23. Bell TJ, Panchal SJ, Miaskowski C, et al,. The prevalence, severity, and impact of opioid-induced bowel dysfunction: Results of a US and European Patient Survey (PROBE 1). Pain Med. 2009; 10: 35-42.
24. Substance Abuse Mental Health Services Administration S. Results from the 2008 National Survey on Drug Use and Health: National Findings. In: Office of Applied Studies NSH-, HHS Publication No. SMA 09-4434. Rockville, MD; 2009: 304.
25. Reid MC, Engles-Horton LL, Weber MAB, et al,. Use of opioid medications for chronic noncancer pain syndromes in primary care. J Gen Intern Med. 2002; 17: 173-179.
26. Robinson RC, Gatchel RJ, Polatin P, et al,. Screening for problematic prescription opioid use. Clin J Pain. 2001; 17: 220-228.
27. Portenoy RK,. Therapeutic use of opioids: Prescribing and control issues. In:, Cooper JR, Czechowicz DJ, Molinari SP, et al., eds. Impact of Prescription Drug Diversion Control Systems on Medical Practice and Patient Care, NIDA Research Monograph 131. Rockville, MD: National Institute on Drug Abuse; 1993: 35-50.
28. Rowbotham MC, Lindsey CD,. How effective is long-term opioid therapy for chronic noncancer pain? Clin J Pain. 2007; 23: 300-302.
29. Ives TJ, Chelminski PR, Hammett-Stabler CA, et al,. Predictors of opioid misuse in patients with chronic pain: A prospective cohort study. BMC Health Serv Res. 2006; 6: 46.
30. Katz NP, Adams EH, Chilcoat H, et al,. Challenges in the development of prescription opioid abuse-deterrent formulations. Clin J Pain. 2007; 23: 648-660.
31. Stinson FS, Grant BF, Dawson DA, et al,. Comorbidity between DSM-IV alcohol and specific drug use disorders in the United States: Results from the National Epidemiologic Survey on Alcohol and Related Conditions. Drug Alcohol Depend. 2005; 80: 105-116.
32. Grant BF, Stinson FS, Dawson DA, et al,. Prevalence and co-occurrence of substance use disorders and independent mood and anxiety disorders: Results from the National Epidemiologic Survey on Alcohol and Related Conditions. Arch Gen Psychiatry. 2004; 61: 807-816.
33. Wu SM, Compton P, Bolus R, et al,. The addiction behaviors checklist: Validation of a new clinician-based measure of inappropriate opioid use in chronic pain. J Pain Symptom Manage. 2006; 32: 342-351.
34. Martins SS, Ghandour LA, Chilcoat HD,. Profile of dependence symptoms among extramedical opioid analgesic users. Addict Behav. 2007; 32: 2003-2019.
35. Miotto K, Compton P, Ling W, et al,. Diagnosing addictive disease in chronic pain patients. Psychosomatics. 1996; 37: 223-225.
36. Simoni-Wastila L, Ritter G, Strickler G,. Gender and other factors associated with nonmedical use of abusable prescription drugs. Subst Use Misuse. 2004; 39: 1-23.
37. Simoni-Wastila L, Strickler G,. Risk factors associated with problem use of prescription drugs. Am J Public Health. 2004; 94: 266-268.
38. Chronic Pain Working Group. The Management of Opioid Therapy for Chronic Pain. Washington, DC: VA Office of Quality and Performance and Quality Management Directorate United States Army MEDCOM; 2003.
39. Fishbain DA, Rosomoff HL, Rosomoff RS,. Drug abuse, dependence, and addiction in chronic pain patients. Clin J Pain. 1992; 8: 77-85.
40. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 4th edn. Washington, DC: American Psychiatric Association; 1994.